These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures. Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017 [TBL] [Abstract][Full Text] [Related]
23. [Platelet antiaggregants in other pathologies]. Jouve R Rev Prat; 1989 Nov; 39(25):2241-3. PubMed ID: 2688045 [TBL] [Abstract][Full Text] [Related]
24. Endovascular procedures for the treatment of autonomic dysfunction. Gibbons C; Cheshire W; Barboi A; Levine B; Olshansky B; Kinsella L; Claydon VE; Crandall C; Fink G; Joyner M; Macefield V; Norcliffe-Kaufmann L; Freeman R; Raj S; Stewart J; Sandroni P; Kaufmann H; Chelimsky T Clin Auton Res; 2014 Feb; 24(1):1-2. PubMed ID: 24178965 [No Abstract] [Full Text] [Related]
25. Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery. Thaler HW; Frisee F; Korninger C J Trauma; 2010 Nov; 69(5):1217-20; discussion 1221. PubMed ID: 21068622 [TBL] [Abstract][Full Text] [Related]
26. The role of platelets and platelet glycoprotein IIb/IIIa receptor inhibition in acute coronary syndromes: an educational supplement. Introduction. Joseph A J Emerg Med; 1999; 17(3):565. PubMed ID: 10338257 [No Abstract] [Full Text] [Related]
27. Stent-assisted coiling of wide-necked aneurysms in the setting of acute subarachnoid hemorrhage: experience in 65 patients. Amenta PS; Dalyai RT; Kung D; Toporowski A; Chandela S; Hasan D; Gonzalez LF; Dumont AS; Tjoumakaris SI; Rosenwasser RH; Maltenfort MG; Jabbour PM Neurosurgery; 2012 Jun; 70(6):1415-29; discussion 1429. PubMed ID: 22186840 [TBL] [Abstract][Full Text] [Related]
28. The use of flow diverter stents in the management of traumatic vertebral artery dissections. Cohen JE; Gomori JM; Moscovici S; Bala M; Itshayek E J Clin Neurosci; 2013 May; 20(5):731-4. PubMed ID: 23391813 [TBL] [Abstract][Full Text] [Related]
29. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis. Eccleston D; Topol EJ Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017 [No Abstract] [Full Text] [Related]
34. [Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: what is evidence based?]. Landgraf H Hamostaseologie; 2006 Aug; 26(3):239-44; quiz 245-6. PubMed ID: 16906242 [TBL] [Abstract][Full Text] [Related]
35. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation. Kleiman NS J Am Coll Cardiol; 2004 Jun; 43(11):1989-91. PubMed ID: 15172402 [No Abstract] [Full Text] [Related]
39. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [TBL] [Abstract][Full Text] [Related]
40. Monitoring anticoagulation of primary haemostasis--estimation of platelet function in whole blood assays. Calatzis A; Leitner M; Panzer S Hamostaseologie; 2009 Aug; 29(3):279-84. PubMed ID: 19644601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]